We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Roche Diagnostics

Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests read more Featured Products: More products

Download Mobile App





Roche Showcases Latest Innovations in Diagnostic Solutions at AACC 2022

By LabMedica International staff writers
Posted on 26 Jul 2022

Roche Diagnostics (Basel, Switzerland) will showcase a cutting-edge interactive and solutions-focused exhibit at the 2022 American Association of Clinical Chemistry (AACC) Scientific Meeting and Clinical Lab Expo, July 24-28 in Chicago. More...



The Roche exhibit booth (No. 2002) will feature the latest solutions that can connect laboratory systems, analyze data and drive new efficiencies so labs have more time to focus on delivering better patient care. To address current laboratory challenges, Roche will also introduce the Roche Idea Lab, where experts in areas critical to laboratory success will provide key insights. These areas include a lab’s success in health equity and testing access, staffing pressures, data optimization, and improving clinical outcomes for patients with cardiometabolic, neurodegenerative and infectious diseases. Roche will also present 11 interactive workshops as part of the Idea Lab to share best practices and provide answers on topics that matter most in today’s evolving lab environment.

The Roche exhibit booth will feature demonstrations of 18 innovative systems, including the cobas pro and cobas pure serum work area solutions, the cobas 5800 molecular system and the cobas pulse point-of-care professional glucose management solution. The cobas 5800 system allows labs to improve the productivity of their floor space by running a broad menu of assays from a small footprint, using fully automated and standardized workflows. The cobas 5800 System helps labs by making automation, consolidation, integration and standardization more accessible than ever before. The cobas pulse system is an industry first professional blood glucose management solution with mobile digital health capabilities to help improve patient care. Designed to help improve workflows and change healthcare in favor of cost efficiency and better patient care, the cobas pulse system is the gateway to the future of digital health.
 

Related Links:
Roche Diagnostics 


New
Gold Member
Automated MALDI-TOF MS System
EXS 3000
Portable Electronic Pipette
Mini 96
New
Gold Member
Collection and Transport System
PurSafe Plus®
New
Homocysteine Quality Control
Liquichek Homocysteine Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: When assessing the same lung biopsy sample, research shows that only 18% of pathologists will agree on a TCMR diagnosis (Photo courtesy of Thermo Fisher)

Molecular Microscope Diagnostic System Assesses Lung Transplant Rejection

Lung transplant recipients face a significant risk of rejection and often require routine biopsies to monitor graft health, yet assessing the same biopsy sample can be highly inconsistent among pathologists.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.